Stem Cell Company Stocks 8/23/09

The Dow is currently at 9500 and everything is moving higher except the stem cell stocks. Even star performers like GERN are CYTX have turned south. This sector is in major need of a catalyst.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- MultiCell Technologies (MCET.OB) = Up 233%; This one spiked on a patent approval. Most traders know this stock has a very tight float and typically makes big moves when it does move. The gains never hold, so don't jump in late.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Bioheart Inc. (BHRT.OB) = Down -27%; The stock dropped for no particular reason and it's currently sitting around its 52 week low. This is potentially a good bounce play, but be careful with the low volume.

Stem Cell Stocks Current Price and % Up or Down 8/10/09 - 8/21/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.12; Up 12%
Aastrom Biosciences (ASTM) = Cur Price: $0.45; Up 2%
BioTime, Inc. (BTIM) = Cur Price: $3.10; Down -12%

Celgene Corp (CELG) = Cur Price: $53.15; Down -3%

Cytori Therapeutics (CYTX) = Cur Price: $3.20; Unchanged
Geron Corp (GERN) = Cur Price: $6.52; Down -15%
ThermoGenesis (KOOL) = Cur Price: $0.69; Unchanged
Osiris Therapeutics (OSIR) = Cur Price: $12.25; Up 7%
StemCell Inc. (STEM) = Cur Price: $1.63; Down -1%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.118; Down -19%
Athersys Inc. (ATHX) = Cur Price: $0.97; Down -5%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.061; Down -13%
Bioheart Inc. (BHRT) = Cur Price: $0.60; Down -27%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0031; Down -3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.00; Up 18%
Neuralstem (CUR) = Cur Price: $1.09; Down -11%
International Stem Cell (ISCO.OB) = Cur Price: $0.82; Down -7%
MultiCell Technologies (MCET.OB) = Cur Price: $0.03; Up 233%
Pluristem Therapeutics (PSTI) = Cur Price: $1.45; Up 4%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.048; Up 7%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0032; Up 14%


Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 8/08/09

The stock market isn't letting up but the stem cell stock trade is practically dead. GERN and CYTX have been solid performers as large caps during the overall market's run. However, the small caps have done basically nothing as a whole. We'll continue to monitor them all.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Brainstorm Cell Therapeutics (BCLI.OB) = Up 37%; This was one of the worst performers two weeks ago. This is typical penny stock action. I wouldn't read too much into this one.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

-Osiris Therapeutics (OSIR) = Down -10%; This stock is hovering around its 52 week low. Keep an eye out for this one. It may be due for a bounce.

Stem Cell Stocks Current Price and % Up or Down 7/27/09 - 8/7/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.89; Up 9%
Aastrom Biosciences (ASTM) = Cur Price: $0.44; Up 13%
BioTime, Inc. (BTIM) = Cur Price: $3.53; Up 9%
Celgene Corp (CELG) = Cur Price: $55.05; Up 1%
Cytori Therapeutics (CYTX) = Cur Price: $3.21; Down -5%
Geron Corp (GERN) = Cur Price: $7.63; Down -5%
ThermoGenesis (KOOL) = Cur Price: $0.69; Up 3%
Osiris Therapeutics (OSIR) = Cur Price: $11.44; Down -10%
StemCell Inc. (STEM) = Cur Price: $1.64; Down -2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.145; Down -11%
Athersys Inc. (ATHX) = Cur Price: $1.02; Up 15%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Up 37%
Bioheart Inc. (BHRT) = Cur Price: $0.82; Up 11%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0032; Down -6%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.70; Down -4%
Neuralstem (CUR) = Cur Price: $1.22; Up 14%
International Stem Cell (ISCO.OB) = Cur Price: $0.88; Down -3%
MultiCell Technologies (MCET.OB) = Cur Price: $0.009; Up 18%
Pluristem Therapeutics (PSTI) = Cur Price: $1.39; Down -3%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.045; Down -10%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0028; Down -7%


Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.